Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 97 | 2023 | 3014 | 8.240 |
Why?
|
Pulmonary Emphysema | 54 | 2021 | 673 | 7.670 |
Why?
|
Tomography, X-Ray Computed | 126 | 2022 | 20308 | 4.950 |
Why?
|
Lung | 84 | 2023 | 9706 | 4.220 |
Why?
|
Lung Diseases, Interstitial | 23 | 2023 | 766 | 2.800 |
Why?
|
Smoking | 53 | 2023 | 8612 | 2.560 |
Why?
|
Respiratory Function Tests | 36 | 2021 | 1673 | 2.380 |
Why?
|
Pulmonary Artery | 17 | 2021 | 1899 | 2.330 |
Why?
|
Airway Remodeling | 10 | 2016 | 141 | 2.190 |
Why?
|
Forced Expiratory Volume | 43 | 2021 | 1724 | 2.090 |
Why?
|
Emphysema | 13 | 2021 | 213 | 1.940 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 14 | 2019 | 1234 | 1.540 |
Why?
|
Pneumonectomy | 9 | 2015 | 1066 | 1.460 |
Why?
|
Thorax | 5 | 2020 | 512 | 1.240 |
Why?
|
Pectoralis Muscles | 3 | 2021 | 85 | 1.220 |
Why?
|
Spirometry | 20 | 2021 | 866 | 1.150 |
Why?
|
Radiography, Thoracic | 9 | 2017 | 1344 | 1.140 |
Why?
|
Bronchography | 4 | 2013 | 73 | 1.120 |
Why?
|
Pulmonary Veins | 7 | 2021 | 709 | 1.060 |
Why?
|
Lung Diseases | 9 | 2022 | 1889 | 1.060 |
Why?
|
Total Lung Capacity | 10 | 2016 | 152 | 0.910 |
Why?
|
Idiopathic Pulmonary Fibrosis | 5 | 2019 | 429 | 0.900 |
Why?
|
Pattern Recognition, Automated | 6 | 2020 | 1019 | 0.830 |
Why?
|
Vital Capacity | 18 | 2022 | 910 | 0.820 |
Why?
|
Respiratory Mechanics | 6 | 2013 | 642 | 0.790 |
Why?
|
Pulmonary Heart Disease | 1 | 2019 | 40 | 0.760 |
Why?
|
Bronchiectasis | 5 | 2022 | 126 | 0.760 |
Why?
|
Mucin-5B | 7 | 2019 | 136 | 0.710 |
Why?
|
Middle Aged | 136 | 2022 | 213752 | 0.680 |
Why?
|
Lung Diseases, Obstructive | 2 | 2021 | 315 | 0.670 |
Why?
|
Exercise Tolerance | 7 | 2022 | 802 | 0.670 |
Why?
|
Dyspnea | 6 | 2015 | 1237 | 0.640 |
Why?
|
Aged | 115 | 2022 | 161488 | 0.640 |
Why?
|
Aortic Diseases | 3 | 2012 | 725 | 0.630 |
Why?
|
Male | 157 | 2022 | 349524 | 0.630 |
Why?
|
Severity of Illness Index | 40 | 2021 | 16008 | 0.630 |
Why?
|
Lung Injury | 2 | 2019 | 396 | 0.630 |
Why?
|
Heart Ventricles | 5 | 2021 | 3851 | 0.630 |
Why?
|
Wolves | 1 | 2016 | 4 | 0.620 |
Why?
|
Female | 158 | 2022 | 375205 | 0.600 |
Why?
|
Humans | 203 | 2023 | 708843 | 0.590 |
Why?
|
Bronchi | 4 | 2016 | 845 | 0.580 |
Why?
|
Pulmonary Fibrosis | 6 | 2021 | 540 | 0.570 |
Why?
|
Bronchiolitis Obliterans | 2 | 2014 | 186 | 0.550 |
Why?
|
Calcinosis | 3 | 2015 | 1435 | 0.540 |
Why?
|
Aortography | 3 | 2015 | 442 | 0.530 |
Why?
|
Algorithms | 13 | 2020 | 13647 | 0.520 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2016 | 241 | 0.480 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2021 | 578 | 0.480 |
Why?
|
Mexican Americans | 1 | 2014 | 172 | 0.480 |
Why?
|
Longitudinal Studies | 24 | 2021 | 13536 | 0.470 |
Why?
|
Reproducibility of Results | 21 | 2019 | 19423 | 0.450 |
Why?
|
Radiographic Image Enhancement | 6 | 2014 | 924 | 0.450 |
Why?
|
Asthma | 7 | 2022 | 5850 | 0.440 |
Why?
|
Bronchodilator Agents | 2 | 2014 | 512 | 0.440 |
Why?
|
Preoperative Period | 1 | 2014 | 552 | 0.440 |
Why?
|
Cohort Studies | 30 | 2022 | 39292 | 0.430 |
Why?
|
Pulmonary Valve | 1 | 2015 | 401 | 0.430 |
Why?
|
Disease Progression | 20 | 2021 | 13298 | 0.430 |
Why?
|
Organ Size | 7 | 2019 | 2317 | 0.420 |
Why?
|
Imaging, Three-Dimensional | 6 | 2019 | 3984 | 0.420 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2012 | 192 | 0.410 |
Why?
|
Hypertension, Pulmonary | 6 | 2021 | 1489 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 8 | 2018 | 34151 | 0.410 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1692 | 0.410 |
Why?
|
Pulmonary Ventilation | 2 | 2009 | 376 | 0.410 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2019 | 8968 | 0.400 |
Why?
|
Densitometry | 1 | 2010 | 171 | 0.390 |
Why?
|
Sensitivity and Specificity | 15 | 2017 | 14836 | 0.370 |
Why?
|
Genetic Predisposition to Disease | 15 | 2019 | 17218 | 0.370 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2009 | 115 | 0.360 |
Why?
|
Genome-Wide Association Study | 12 | 2020 | 11738 | 0.360 |
Why?
|
Tomography, Optical Coherence | 2 | 2012 | 2483 | 0.350 |
Why?
|
Linear Models | 11 | 2019 | 5986 | 0.330 |
Why?
|
Nutrition Surveys | 1 | 2014 | 1539 | 0.320 |
Why?
|
Multivariate Analysis | 15 | 2019 | 12447 | 0.310 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6170 | 0.300 |
Why?
|
Trachea | 3 | 2013 | 1076 | 0.300 |
Why?
|
Diagnostic Imaging | 3 | 2019 | 3495 | 0.290 |
Why?
|
Arteriosclerosis | 1 | 2010 | 1202 | 0.280 |
Why?
|
Predictive Value of Tests | 12 | 2020 | 15252 | 0.280 |
Why?
|
Regression Analysis | 8 | 2019 | 6451 | 0.280 |
Why?
|
Aged, 80 and over | 32 | 2022 | 58184 | 0.270 |
Why?
|
Hemodynamics | 2 | 2021 | 4211 | 0.270 |
Why?
|
Polymorphism, Genetic | 5 | 2017 | 4293 | 0.270 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1045 | 0.260 |
Why?
|
Genetic Loci | 4 | 2019 | 2587 | 0.260 |
Why?
|
Airway Obstruction | 4 | 2014 | 651 | 0.260 |
Why?
|
Liver Transplantation | 1 | 2015 | 2022 | 0.260 |
Why?
|
Bronchitis, Chronic | 2 | 2014 | 65 | 0.250 |
Why?
|
Aorta | 3 | 2019 | 2120 | 0.250 |
Why?
|
Echocardiography | 3 | 2021 | 5139 | 0.240 |
Why?
|
Pulmonary Embolism | 3 | 2021 | 2371 | 0.240 |
Why?
|
Case-Control Studies | 16 | 2020 | 21194 | 0.240 |
Why?
|
Residual Volume | 3 | 2011 | 41 | 0.230 |
Why?
|
Prognosis | 14 | 2021 | 28919 | 0.230 |
Why?
|
Proportional Hazards Models | 11 | 2022 | 12292 | 0.230 |
Why?
|
Pulmonary Diffusing Capacity | 3 | 2013 | 91 | 0.220 |
Why?
|
Azithromycin | 2 | 2014 | 180 | 0.220 |
Why?
|
Observer Variation | 5 | 2017 | 2687 | 0.220 |
Why?
|
Tobacco Smoke Pollution | 3 | 2019 | 771 | 0.210 |
Why?
|
Hospitalization | 4 | 2015 | 9644 | 0.210 |
Why?
|
Schistosomiasis | 1 | 2021 | 51 | 0.210 |
Why?
|
Molecular Epidemiology | 2 | 2022 | 477 | 0.210 |
Why?
|
Lung Volume Measurements | 3 | 2013 | 358 | 0.210 |
Why?
|
Respiratory System Abnormalities | 1 | 2021 | 71 | 0.210 |
Why?
|
Posture | 1 | 2005 | 989 | 0.210 |
Why?
|
Phenotype | 14 | 2022 | 16306 | 0.210 |
Why?
|
Respiratory Tract Diseases | 2 | 2018 | 684 | 0.200 |
Why?
|
Environmental Exposure | 4 | 2019 | 3954 | 0.200 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2163 | 0.190 |
Why?
|
Risk Factors | 23 | 2021 | 69553 | 0.190 |
Why?
|
Blood Vessels | 2 | 2018 | 1165 | 0.190 |
Why?
|
Fibrinolytic Agents | 2 | 2020 | 2129 | 0.190 |
Why?
|
Exhalation | 3 | 2013 | 175 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2019 | 15485 | 0.190 |
Why?
|
Follow-Up Studies | 17 | 2021 | 39038 | 0.180 |
Why?
|
Esophagus | 1 | 2005 | 1019 | 0.180 |
Why?
|
Adult | 32 | 2022 | 211041 | 0.180 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 77 | 0.180 |
Why?
|
Survival Rate | 7 | 2021 | 13202 | 0.180 |
Why?
|
Sex Factors | 7 | 2020 | 10566 | 0.180 |
Why?
|
Phlebography | 1 | 2019 | 328 | 0.180 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2014 | 5135 | 0.180 |
Why?
|
Logistic Models | 10 | 2019 | 13468 | 0.170 |
Why?
|
Quality of Life | 9 | 2022 | 11594 | 0.170 |
Why?
|
Tidal Volume | 2 | 2011 | 479 | 0.170 |
Why?
|
Risk Assessment | 10 | 2021 | 23284 | 0.170 |
Why?
|
Respiratory System | 2 | 2019 | 560 | 0.170 |
Why?
|
Bronchoscopy | 2 | 2018 | 842 | 0.170 |
Why?
|
Therapy, Computer-Assisted | 1 | 2019 | 276 | 0.160 |
Why?
|
Muscular Atrophy | 1 | 2021 | 352 | 0.160 |
Why?
|
Particulate Matter | 4 | 2019 | 2288 | 0.160 |
Why?
|
DNA | 3 | 2018 | 7172 | 0.160 |
Why?
|
Mortality | 2 | 2019 | 2732 | 0.160 |
Why?
|
Prevalence | 12 | 2017 | 14712 | 0.150 |
Why?
|
Pneumococcal Vaccines | 2 | 2012 | 429 | 0.150 |
Why?
|
Cardiac Volume | 1 | 2017 | 214 | 0.150 |
Why?
|
Pleural Diseases | 1 | 2017 | 131 | 0.150 |
Why?
|
Asbestos | 1 | 2017 | 188 | 0.150 |
Why?
|
Pleura | 1 | 2017 | 231 | 0.140 |
Why?
|
Clothing | 1 | 2016 | 91 | 0.140 |
Why?
|
Retrospective Studies | 16 | 2022 | 71483 | 0.140 |
Why?
|
Models, Economic | 1 | 2020 | 723 | 0.140 |
Why?
|
Cryopreservation | 1 | 2020 | 618 | 0.140 |
Why?
|
Promoter Regions, Genetic | 5 | 2019 | 6068 | 0.140 |
Why?
|
Cross-Sectional Studies | 9 | 2022 | 23020 | 0.140 |
Why?
|
Tomography, Spiral Computed | 2 | 2014 | 293 | 0.140 |
Why?
|
Vasodilation | 1 | 2019 | 968 | 0.140 |
Why?
|
Radiation Dosage | 3 | 2019 | 2041 | 0.140 |
Why?
|
Statistics as Topic | 3 | 2011 | 2402 | 0.140 |
Why?
|
Vasodilator Agents | 1 | 2019 | 1010 | 0.140 |
Why?
|
Iceland | 3 | 2020 | 182 | 0.140 |
Why?
|
Ventricular Function | 1 | 2017 | 427 | 0.140 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 636 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2014 | 15053 | 0.130 |
Why?
|
Autophagy | 2 | 2013 | 1343 | 0.130 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 267 | 0.130 |
Why?
|
Galectin 3 | 1 | 2016 | 217 | 0.130 |
Why?
|
Respiratory Muscles | 1 | 2014 | 138 | 0.130 |
Why?
|
United States | 16 | 2021 | 67165 | 0.130 |
Why?
|
Muscle Strength | 1 | 2018 | 570 | 0.130 |
Why?
|
Blood Volume | 1 | 2015 | 590 | 0.120 |
Why?
|
ROC Curve | 4 | 2017 | 3518 | 0.120 |
Why?
|
Endotoxins | 1 | 2016 | 558 | 0.120 |
Why?
|
Busulfan | 1 | 2014 | 271 | 0.120 |
Why?
|
Oxygen Consumption | 3 | 2022 | 1928 | 0.120 |
Why?
|
Radiography | 6 | 2016 | 6989 | 0.120 |
Why?
|
Sheep | 1 | 2016 | 1484 | 0.120 |
Why?
|
Prospective Studies | 14 | 2021 | 50597 | 0.120 |
Why?
|
Seasons | 1 | 2019 | 1433 | 0.120 |
Why?
|
Nitric Oxide | 2 | 2019 | 2122 | 0.120 |
Why?
|
Body Mass Index | 7 | 2021 | 12366 | 0.120 |
Why?
|
Gene Expression Regulation | 4 | 2019 | 12447 | 0.110 |
Why?
|
Temperature | 1 | 2019 | 2144 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2018 | 936 | 0.110 |
Why?
|
Exercise Test | 5 | 2022 | 2125 | 0.110 |
Why?
|
Odds Ratio | 3 | 2021 | 9754 | 0.110 |
Why?
|
Pulmonary Edema | 1 | 2014 | 418 | 0.110 |
Why?
|
Phantoms, Imaging | 4 | 2017 | 2401 | 0.110 |
Why?
|
Simvastatin | 1 | 2014 | 356 | 0.110 |
Why?
|
Contrast Media | 3 | 2014 | 5267 | 0.110 |
Why?
|
Pulmonary Circulation | 1 | 2014 | 737 | 0.110 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 517 | 0.100 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2011 | 94 | 0.100 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 384 | 0.100 |
Why?
|
Cysts | 1 | 2015 | 630 | 0.100 |
Why?
|
Bronchioles | 1 | 2010 | 30 | 0.100 |
Why?
|
Fibrinogen | 1 | 2014 | 914 | 0.100 |
Why?
|
Inhalation Exposure | 1 | 2013 | 441 | 0.100 |
Why?
|
Orthomyxoviridae Infections | 3 | 1997 | 232 | 0.100 |
Why?
|
Normal Distribution | 1 | 2011 | 278 | 0.100 |
Why?
|
Vehicle Emissions | 1 | 2015 | 626 | 0.100 |
Why?
|
Thymus Gland | 1 | 2015 | 1328 | 0.100 |
Why?
|
Acute Disease | 5 | 2021 | 7158 | 0.100 |
Why?
|
Population Surveillance | 1 | 2021 | 2606 | 0.100 |
Why?
|
Biological Products | 1 | 2018 | 825 | 0.100 |
Why?
|
Air Pollution | 2 | 2019 | 1985 | 0.100 |
Why?
|
Cilia | 1 | 2013 | 471 | 0.100 |
Why?
|
Hydroxyurea | 1 | 2011 | 290 | 0.090 |
Why?
|
Walking | 3 | 2013 | 1096 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3562 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1224 | 0.090 |
Why?
|
Body Composition | 2 | 2021 | 2393 | 0.090 |
Why?
|
Comorbidity | 6 | 2017 | 10339 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2095 | 0.090 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 594 | 0.090 |
Why?
|
Cause of Death | 2 | 2020 | 3497 | 0.090 |
Why?
|
Arthritis, Rheumatoid | 2 | 2015 | 3609 | 0.090 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 570 | 0.090 |
Why?
|
Demography | 1 | 2014 | 1596 | 0.090 |
Why?
|
Boston | 3 | 2017 | 9402 | 0.090 |
Why?
|
Hemagglutinins, Viral | 3 | 1997 | 65 | 0.090 |
Why?
|
African Americans | 3 | 2015 | 5118 | 0.090 |
Why?
|
Age Factors | 8 | 2021 | 18712 | 0.090 |
Why?
|
Perfusion Imaging | 1 | 2010 | 189 | 0.090 |
Why?
|
Histone Deacetylases | 1 | 2013 | 758 | 0.090 |
Why?
|
Fibroblasts | 1 | 2019 | 4299 | 0.090 |
Why?
|
Health Services | 1 | 2013 | 732 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 3097 | 0.090 |
Why?
|
Helium | 1 | 2008 | 120 | 0.080 |
Why?
|
Occupational Diseases | 1 | 2016 | 1298 | 0.080 |
Why?
|
Williams Syndrome | 1 | 2010 | 183 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2021 | 3436 | 0.080 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 360 | 0.080 |
Why?
|
Gastroesophageal Reflux | 1 | 2014 | 701 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2021 | 4658 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 2010 | 607 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 2011 | 485 | 0.080 |
Why?
|
Inflammasomes | 1 | 2012 | 420 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1478 | 0.080 |
Why?
|
Pneumococcal Infections | 1 | 2012 | 556 | 0.080 |
Why?
|
Critical Illness | 1 | 2019 | 2496 | 0.080 |
Why?
|
Transplantation Conditioning | 1 | 2014 | 1553 | 0.080 |
Why?
|
Patient Selection | 2 | 2010 | 4306 | 0.080 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2013 | 1156 | 0.080 |
Why?
|
Genotype | 7 | 2018 | 12863 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2016 | 1520 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2011 | 6530 | 0.070 |
Why?
|
Ultrasonography | 1 | 2019 | 5918 | 0.070 |
Why?
|
Elasticity Imaging Techniques | 1 | 2011 | 366 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2014 | 1154 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2011 | 692 | 0.070 |
Why?
|
Pulmonary Medicine | 1 | 2007 | 215 | 0.070 |
Why?
|
Social Class | 1 | 2014 | 1925 | 0.070 |
Why?
|
Air Pollutants | 2 | 2019 | 2592 | 0.070 |
Why?
|
Adiposity | 1 | 2014 | 1734 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 6991 | 0.070 |
Why?
|
Aging | 2 | 2021 | 8358 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2709 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9641 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4493 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4099 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1421 | 0.060 |
Why?
|
Ozone | 2 | 2019 | 450 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2759 | 0.060 |
Why?
|
Incidence | 5 | 2017 | 20320 | 0.060 |
Why?
|
Cluster Analysis | 3 | 2019 | 2750 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2011 | 2716 | 0.060 |
Why?
|
Manometry | 1 | 2005 | 419 | 0.060 |
Why?
|
Cystic Fibrosis | 1 | 2012 | 1156 | 0.060 |
Why?
|
Young Adult | 5 | 2021 | 55940 | 0.060 |
Why?
|
Gene Expression | 2 | 2014 | 8014 | 0.060 |
Why?
|
Self Report | 1 | 2014 | 3397 | 0.060 |
Why?
|
Age of Onset | 3 | 2015 | 3330 | 0.060 |
Why?
|
Image Enhancement | 2 | 2011 | 2975 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3696 | 0.060 |
Why?
|
Traction | 1 | 2022 | 103 | 0.060 |
Why?
|
Administration, Inhalation | 2 | 2019 | 1102 | 0.060 |
Why?
|
Models, Statistical | 2 | 2015 | 5034 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4383 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 2818 | 0.050 |
Why?
|
Sex Distribution | 3 | 2014 | 2328 | 0.050 |
Why?
|
Area Under Curve | 2 | 2016 | 1688 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4592 | 0.050 |
Why?
|
Software | 2 | 2020 | 4345 | 0.050 |
Why?
|
Angiography | 2 | 2019 | 1675 | 0.050 |
Why?
|
Mothers | 1 | 2011 | 1991 | 0.050 |
Why?
|
Oxygen | 2 | 2023 | 4150 | 0.050 |
Why?
|
Heart | 1 | 2014 | 4315 | 0.050 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 9 | 0.050 |
Why?
|
Stroke Volume | 3 | 2022 | 4522 | 0.050 |
Why?
|
Apoptosis | 2 | 2014 | 10085 | 0.050 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2017 | 935 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4969 | 0.050 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 161 | 0.050 |
Why?
|
Quantitative Trait Loci | 2 | 2018 | 1976 | 0.050 |
Why?
|
beta Karyopherins | 1 | 2019 | 49 | 0.050 |
Why?
|
Catheterization | 1 | 2005 | 1463 | 0.050 |
Why?
|
Artifacts | 2 | 2019 | 1904 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4254 | 0.050 |
Why?
|
APACHE | 1 | 2019 | 270 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 3026 | 0.050 |
Why?
|
Cytokines | 1 | 2014 | 7189 | 0.050 |
Why?
|
Heart Failure | 1 | 2022 | 10040 | 0.040 |
Why?
|
Time Factors | 5 | 2019 | 41038 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 36 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2019 | 61932 | 0.040 |
Why?
|
Occupations | 1 | 2020 | 469 | 0.040 |
Why?
|
Vascular Resistance | 1 | 2021 | 959 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 5141 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 2 | 2013 | 1108 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2019 | 1969 | 0.040 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 145 | 0.040 |
Why?
|
Bronchial Arteries | 1 | 2016 | 20 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3968 | 0.040 |
Why?
|
Telomere | 1 | 2022 | 823 | 0.040 |
Why?
|
Animals | 11 | 2017 | 170486 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2014 | 20170 | 0.040 |
Why?
|
Galactosides | 1 | 1996 | 52 | 0.040 |
Why?
|
Treatment Failure | 2 | 2014 | 2680 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6338 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2021 | 1192 | 0.040 |
Why?
|
Antibodies, Heterophile | 1 | 1996 | 129 | 0.040 |
Why?
|
Carbon | 1 | 2019 | 649 | 0.040 |
Why?
|
Reference Standards | 1 | 2019 | 992 | 0.040 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2019 | 403 | 0.040 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2015 | 58 | 0.040 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2015 | 59 | 0.040 |
Why?
|
Calibration | 1 | 2017 | 802 | 0.030 |
Why?
|
Health Status | 3 | 2013 | 4015 | 0.030 |
Why?
|
Mice | 10 | 2017 | 80876 | 0.030 |
Why?
|
snRNP Core Proteins | 1 | 2014 | 21 | 0.030 |
Why?
|
Mannosidases | 1 | 2014 | 21 | 0.030 |
Why?
|
alpha-Mannosidase | 1 | 2014 | 21 | 0.030 |
Why?
|
Microcirculation | 1 | 2019 | 1301 | 0.030 |
Why?
|
Artificial Intelligence | 1 | 2006 | 1661 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2014 | 22989 | 0.030 |
Why?
|
Sex Characteristics | 2 | 2015 | 2510 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5182 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2014 | 5045 | 0.030 |
Why?
|
Oligosaccharides | 1 | 1996 | 398 | 0.030 |
Why?
|
Air Pollutants, Occupational | 1 | 2016 | 367 | 0.030 |
Why?
|
Influenza A virus | 1 | 1997 | 452 | 0.030 |
Why?
|
Dynamins | 1 | 2014 | 145 | 0.030 |
Why?
|
Phenylbutyrates | 1 | 2013 | 71 | 0.030 |
Why?
|
United States Environmental Protection Agency | 1 | 2013 | 132 | 0.030 |
Why?
|
Thiolester Hydrolases | 1 | 2014 | 87 | 0.030 |
Why?
|
RNA Helicases | 1 | 2014 | 135 | 0.030 |
Why?
|
Radiology | 1 | 2007 | 1931 | 0.030 |
Why?
|
Inhalation | 1 | 2013 | 149 | 0.030 |
Why?
|
Spain | 1 | 2014 | 455 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2014 | 323 | 0.030 |
Why?
|
Smoke | 1 | 2014 | 215 | 0.030 |
Why?
|
Automation | 1 | 2015 | 589 | 0.030 |
Why?
|
Epigenomics | 1 | 2018 | 802 | 0.030 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2014 | 181 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 577 | 0.030 |
Why?
|
Quinazolinones | 1 | 2014 | 230 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2014 | 520 | 0.030 |
Why?
|
Length of Stay | 2 | 2019 | 6257 | 0.030 |
Why?
|
Mucus | 1 | 2013 | 315 | 0.030 |
Why?
|
Thigh | 1 | 2013 | 232 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2012 | 4422 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2013 | 306 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2015 | 543 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 1001 | 0.030 |
Why?
|
Tobacco | 1 | 2014 | 389 | 0.030 |
Why?
|
Caspase 1 | 1 | 2012 | 218 | 0.030 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2013 | 330 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 1021 | 0.030 |
Why?
|
Leukotriene E4 | 1 | 2011 | 71 | 0.030 |
Why?
|
Bleomycin | 1 | 2012 | 503 | 0.030 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2010 | 75 | 0.030 |
Why?
|
Chemokines | 1 | 2015 | 954 | 0.030 |
Why?
|
Serpin E2 | 1 | 2010 | 52 | 0.030 |
Why?
|
Observation | 1 | 2012 | 310 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2013 | 962 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 402 | 0.020 |
Why?
|
Macrolides | 1 | 2011 | 215 | 0.020 |
Why?
|
Cytosol | 1 | 2013 | 938 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1646 | 0.020 |
Why?
|
China | 1 | 2016 | 2251 | 0.020 |
Why?
|
Elastic Modulus | 1 | 2011 | 223 | 0.020 |
Why?
|
Antigen Presentation | 1 | 1996 | 1303 | 0.020 |
Why?
|
Caspase 3 | 1 | 2012 | 805 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2068 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2013 | 731 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 12183 | 0.020 |
Why?
|
Leukotriene B4 | 1 | 2011 | 317 | 0.020 |
Why?
|
Epoxide Hydrolases | 1 | 2010 | 126 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3411 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 336 | 0.020 |
Why?
|
Antibodies, Viral | 2 | 1997 | 2930 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 6156 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 423 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 998 | 0.020 |
Why?
|
Functional Residual Capacity | 1 | 2008 | 69 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 3994 | 0.020 |
Why?
|
Nasopharynx | 1 | 2011 | 387 | 0.020 |
Why?
|
Education | 1 | 2012 | 540 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2421 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1002 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 2064 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1715 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 1997 | 9584 | 0.020 |
Why?
|
Isotopes | 1 | 2008 | 123 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2009 | 274 | 0.020 |
Why?
|
Elastin | 1 | 2010 | 332 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1126 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1920 | 0.020 |
Why?
|
tau Proteins | 1 | 2018 | 1623 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 803 | 0.020 |
Why?
|
Alabama | 1 | 2007 | 90 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5235 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1875 | 0.020 |
Why?
|
Genetic Markers | 1 | 2014 | 2690 | 0.020 |
Why?
|
Protein Kinases | 1 | 2014 | 1680 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10507 | 0.020 |
Why?
|
Autoantibodies | 1 | 2015 | 1976 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1461 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1594 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2014 | 5908 | 0.020 |
Why?
|
Rest | 1 | 2011 | 868 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 5041 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4837 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2019 | 5095 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6048 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 7090 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3693 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2010 | 1380 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 2035 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 2062 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1851 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4293 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1860 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8024 | 0.020 |
Why?
|
Neutralization Tests | 2 | 1997 | 735 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1805 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 1997 | 4861 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6562 | 0.020 |
Why?
|
Probability | 1 | 2009 | 2474 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2011 | 1080 | 0.020 |
Why?
|
Streptococcus pneumoniae | 1 | 2009 | 780 | 0.020 |
Why?
|
Electrocardiography | 1 | 2017 | 6386 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2009 | 1481 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3701 | 0.010 |
Why?
|
Registries | 1 | 2019 | 7989 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2011 | 1423 | 0.010 |
Why?
|
Lipids | 1 | 2014 | 3246 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5300 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2013 | 3690 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3156 | 0.010 |
Why?
|
Mitochondria | 1 | 2014 | 3665 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8255 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4226 | 0.010 |
Why?
|
Mice, SCID | 2 | 1997 | 2835 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2014 | 10362 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6765 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 84718 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 15274 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4969 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1997 | 392 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2011 | 11877 | 0.010 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1997 | 315 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6213 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 1995 | 3275 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1996 | 343 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8712 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 5833 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1996 | 416 | 0.010 |
Why?
|
Vaccines, Inactivated | 1 | 1996 | 182 | 0.010 |
Why?
|
Complement C3 | 1 | 1997 | 462 | 0.010 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1996 | 152 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1997 | 633 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1995 | 446 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1995 | 500 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7487 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 1996 | 981 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1995 | 952 | 0.010 |
Why?
|
Viral Vaccines | 1 | 1996 | 629 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1995 | 1527 | 0.010 |
Why?
|
Epitopes | 1 | 1996 | 2646 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2165 | 0.010 |
Why?
|
Blotting, Western | 1 | 1996 | 5456 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 20172 | 0.010 |
Why?
|
Immunotherapy, Adoptive | 1 | 1995 | 1017 | 0.000 |
Why?
|
Child | 1 | 2014 | 73636 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1996 | 6684 | 0.000 |
Why?
|
Mutation | 1 | 2010 | 29262 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 18748 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1997 | 18375 | 0.000 |
Why?
|